Description

The purpose of this Notice of Amendment is to notify about the addition of casirivimab and imdevimab to the Prescription Drug List (PDL) for human and veterinary use.

Resources

Name	Format	Description	Link
Notice: Prescription Drug List (PDL): Casirivimab and Imdevimab (COVID-19)	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-casirivimab-imdevimab-covid19.html
Notice: Prescription Drug List (PDL): Casirivimab and Imdevimab (COVID-19)	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-concernant-modifications/modification-casirivimab-imdevimab-covid19.html

Tags

Topics

Categories